Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy

PURPOSE: As previously reported, treatment of high-grade cervical dysplasia with VGX-3100 resulted in complete histopatho-logic regression (CR) concomitant with elimination of HPV16/18 infection in 40.0% of VGX-3100–treated patients compared with only 14.3% in placebo recipients in a randomized phas...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Morrow, Matthew P., Kraynyak, Kimberly A., Sylvester, Albert J., Dallas, Michael, Knoblock, Dawson, Boyer, Jean D., Yan, Jian, Vang, Russell, Khan, Amir S., Humeau, Laurent, Sardesai, Niranjan Y., Kim, J. Joseph, Plotkin, Stanley, Weiner, David B., Trimble, Cornelia L., Bagarazzi, Mark L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956401/
https://ncbi.nlm.nih.gov/pubmed/29084917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2335
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia